Strategic Focus on Artificial Heart and Assist Devices Industry

Strategic Focus on Artificial Heart and Assist Devices Industry

The artificial heart is a device that replaces the heart. An artificial heart is typically used to bridge the time of heart transplantation or to permanently replace the heart if a heart transplant is not possible. Although other similar inventions began in the late 1940s, the first artificial heart to be successfully implanted in humans was the Jarvik-7, designed in 1982 by a team including Willem Johan Kolff and Robert Jarvik.

Get Sample PDF

Some of the key players of Artificial Heart and Assist Devices Industry:

BiVACOR, SynCardia, Jarvik Heart, CARMAT, AbioMed, LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, Tianjin Medical

An artificial heart is different from a ventricular assist device (VAD) designed to support a failed heart. It is also distinguished from the cardiopulmonary bypass machine, which is an external device used to provide the functions of the heart and lungs, it is used only for a few hours at a time and is most commonly used during heart surgery.

Synthetic replacements for the lungs remain the "Holy Grail" that has long been sought in modern medicine. The obvious advantage of a functional artificial heart is that it reduces the need for lung transplantation as the demand for organs always greatly exceeds the supply.

Comments

Popular posts from this blog

Cystoscope Market Estimate to Boost Growth in Demand by 2027 with Top Key Players: Henke-Sass Wolf, Olympus Corporation, Stryker, NeoScope Inc., KARL STORZ SE & Co. KG

Future Scope for Deep Sea Exploration Robot Industry

Huge Demand for Weather Radar Industry